A C/T polymorphism in CD40 gene is not associated with susceptibility and phenotype of Graves' disease in Taiwanese

Endocrine Journal

Volumn 55, Issue 3, 2008, Pages 477-484

  Hsiao, Jeng Yueh ^a   Tien, Kai Jen ^b   Hsiao, Cheng Ting ^c   Hsieh, Ming Chia ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

CD40; Gene polymorphisms; Graves' disease; SNP

Indexed keywords

CD40 ANTIGEN; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; ALLELE; ARTICLE; CLINICAL STUDY; CONTROL GROUP; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; GRAVES DISEASE; HUMAN; HYPERTHYROIDISM; LABORATORY; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; RELAPSE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL SIGNIFICANCE; TAIWAN;

ADULT; AGE OF ONSET; ANTIGENS, CD40; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TAIWAN;

EID: 46749096373     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K07E-071     Document Type: Article

References (28)

1. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, Evans JG, Young E, Bird T, Smith PA (1977) The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf) 7(6): 481-493.
2. Davies TF (2000) Graves' diseases: Pathogenesis. In: Braverman LE, Utiger RD, editors. Werner and Ingbar's. The thyroid: a fundamental and clinical text. Philadelphia: Lippincott Williams & Wilkins; 518-530.
3. Stenszky V, Kozma L, Balázs C, Rochlitz S, Bear JC, Farid NR (1985) The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab. 61(4): 735-740.
4. Tomer Y, Concepcion E, Greenberg DA (2002) A C/T single nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12(12): 1129-1135.
5. Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) Graves' disease associated Kozak sequence SNP enhances the efficiency of CD40 gene translation: A case for translational pathophysiology. Endocrinology 146(6): 2684-2691.
6. Kim TY, Park YJ, Hwang JK, Song JY, Park KS, Cho BY, Park DJ (2003) A C/T polymorphism in the 5′-untranslated region of the CD40 gene is associated with Graves' disease in Koreans. Thyroid 13(10): 919-925.
7. Heward JM, Simmonds MJ, Carr-Smith J, Foxall H, Franklyn JA, Gough SC (2004) A single nucleotide polymorphism in the CD40 gene on chromosome 20q (GD-2) provides no evidence for susceptibility to Graves' disease in UK Caucasians. Clinical Endocrinology 61(2): 269-272.
8. Houston FA, Wilson V, Jennings CE, Owen CJ, Donaldson P, Perros P, Pearce SH (2004) Role of the CD40 locus in Graves'disease. Thyroid 14(7): 506-509.
9. Simmonds MJ, Gough SC (2005) Genetic insights into disease mechanisms of autoimmunity. Br Med Bull 71: 93-113.
10. Tomer Y, Davies TF (2003) Searching for the autoimmune thyroid disease susceptibility genes: From gene mapping to gene function. Endocr Rev 24(5): 694-717.
11. Vaidya B, Kendall-Taylor P, Pearce SH (2002) The genetics of autoimmune thyroid disease. J Clin Endocrinol Metab. 87(12): 5385-5397.
12. Ban Y, Tozaki T, Taniyama M, Tomita M, Ban Y (2006) Association of a C/T single-nucleotide polymorphism in the 5′ untranslated region of the CD40 gene with Graves' disease in Japanese. Thyroid 16(5): 443-446.
13. Mukai T, Hiromatsu Y, Fukutani T, Ichimura M, Kaku H, Miyake I, Yamada K (2005) A C/T polymorphism in the 5′ untranslated region of the CD40 gene is associated with later onset of Graves' disease in Japanese. Endocr J. 52(4): 471-477.
14. Chistiakov DA, Savost'anov KV, Turakulov Rl, Petunina N, Balabolkin MI, Nosikov VV (2002) Further studies of genetic susceptibility to Graves' disease in a Russian population. Med Sci Monit. 8(3): CR180-184.
15. Ban Y, Greenberg DA, Concepcion ES, Tomer Y (2002) A germline single nucleotide polymorphism at the intracellular domain of the human thyrotropin receptor does not have a major effect on the development of Graves' disease. Thyroid 12(12): 1079-1083.
16. Ho SC, Goh SS, Khoo DH (2003) Association of Graves' disease with intragenic polymorphism of the thyrotropin receptor gene in a cohort of Singapore patients of multi-ethnic origins. Thyroid 13(6): 523-528.
17. Hiratani H, Bowden DW, Ikegami S, Shirasawa S, Shimizu A, Iwatani Y, Akamizu T (2005) Multiple SNPs in intron 7 of thyrotropin receptor are associated with Graves' disease. J Clin Endocrinol Metab. 90(5): 2898-2903.
18. Weetman AP (2000) Graves' Disease. N Engl J Med. 343(17): 1236-1248.
19. Metcalfe RA, McIntosh RS, Marelli-Berg F, Lombardi G, Lechler R, Weetman AP (1998) Detection of CD40 on human thyroid follicular cells: analysis of expression and function. J Clin Endocrinol Metab. 83(4): 1268-1274.
20. Smith TJ, Sciaky D, Phipps RP, Jennings TA (1999) CD40 expression in human thyroid tissue: evidence for involvement of multiple cell types in autoimmune and neoplastic diseases. Thyroid 9(8): 749-755.
21. Faure GC, Bensoussan-Lejzerowicz D, Bene MC, Aubert V, Leclere J (1997) Coexpression of CD40 and class II lantigen HLA-DR in Graves' disease thyroid epithelial cells. Clin Immunol Immunopathol. 84(2): 212-215.
22. Hanafusa T, Pujol-Borrell R, Chiovato L, Russell RC, Doniach D, Bottazzo GF (1983) Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2(8359): 1111-1115.
23. Larsen PR, Ingbar SH (2000) The thyroid gland. In Williams' Textbook of Endocrinology, pp. 357-487.
24. Hsiao JY, Hsieh MC, Tien KJ, Hsu SC, Shin SJ, Lin SR (2007) Association between a C/T polymorphism in exon 33 of the thyroglobulin gene is associated with relapse of Graves' hyperthyroidism after antithyroid withdrawal in Taiwanese. J Clin Endocrinol Metab. 92(8): 3197-3201.
25. Wang PW, Liu RT, Tung SC, Chien WY, Lu YC, Chen CH, Kuo MC, Hsieh JR, Wang ST (1998) Outcome of Graves' disease after antithyroid drug treatment in Taiwan. J Formos Med Assoc. 97(9): 619-625.
26. Wang PW, Liu RT, Juo SH, Wang ST, Hu YH, Hsieh CJ, Chen MH, Chen IY, Wu CL (2004) Cytotoxic T Lymphocyte-Associated Molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal. J Clin Endocrinol Metab. 89(1): 169-173.
27. Tomer Y, Greenberg DA, Concepcion E, Ban Y, Davies TF (2002) Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid disease. J Clin Endocrinol Metab. 87(1): 404-407.
28. Fleiss JL, John W (1981) Statistical Methods for Rates and Proportions, 2nd edn, New York.